Abstract
Lymphocyte predominance Hodgkin’s disease differs from nodular sclerosis and mixed cellularity disease both clinically and histopathologically [47.1]. This chapter is concerned with the patterns of presentation, stage, median time to recurrence, pattern of late recurrences, the risk of secondary non-Hodgkin’s lymphomas, and the low mortality of this entity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Trudel MA, Krikorian JG, Neiman RS. Lymphocyte predominance Hodgkin’s disease. A clinicopathologic reassessment. Cancer 1987; 59: 99–106.
Regula DP Jr., Hoppe RT, Weiss LM. Nodular and diffuse types of lymphocyte-predominance Hodgkin’s disease. N Engl J Med 1988; 318: 214–9.
Borg-Grech A, Radford JA, Crowther D, Swindell R, Harris M. A comparative study of the nodular and diffuse variants of lymphocyte predominant Hodgkin’s disease. J Clin Oncol 1989; 7: 1303–9.
Tefferi A, Zellers RA, Banks PM, Therneau TM, Colgan JP. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin’s disease. J Clin Oncol 1990; 8: 1959–65.
Crennan E, D’Costa I, Liew KH et al. Lymphocyte predominant Hodgkin’s disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes. Int J Radiat Oncol Biol Phys 1995; 31: 333–7.
Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA. Nodular type of lymphocyte predominant Hodgkin’s disease. A clinical study of 50 cases. Ann Oncol 1995; 6: 559–65.
Bodis S, Kraus MD, Pinkus G et al. Clinical presentation and outcome in lymphocyte-predominant Hodgkin’s disease. J Clin Oncol 1997; 15: 3060–6.
Mauch PM, Kalish LA, Kadin M et al. Pattern of presentation of Hodgkin’s disease. Implications for etiology and pathogenesis. Cancer 1993; 71: 2062–71.
Further Reading
Pinkus GS, Said JW. Hodgkin’s disease, lymphocyte predominance type, nodular — a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen. Am J Pathol 1985; 118: 1–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag London
About this chapter
Cite this chapter
Mauch, P.M. (1999). Should lymphocyte predominance Hodgkin’s disease be treated like classical Hodgkin’s disease?. In: Mason, D.Y., Harris, N.L. (eds) Human Lymphoma: Clinical Implications of the REAL Classification. Springer, London. https://doi.org/10.1007/978-1-4471-0857-3_47
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0857-3_47
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1218-1
Online ISBN: 978-1-4471-0857-3
eBook Packages: Springer Book Archive